EPICS Global Perspectives in Lung Cancer

Expert perspectives and strategic insights on the latest therapeutic developments in lung cancer treatment.

February 8 & 9, 2021
Corey Langer MD Scientific Leader Faculty Chair Aptitude Health

Faculty Chair

Corey Langer, MD, FACP

University of Pennsylvania, US


Benjamin Besse, MD, PhD
Institute Gustave Roussy
Villejuif, France

Marina Chiara Garassino, MD 
Istituto Nazionale dei Tumori
Milan, Italy

Roy S. Herbst, MD, PhD
Yale Cancer Center
New Haven, CT, US

Solange Peters, MD, PhD
University Hospital of Lausanne
Lausanne, Switzerland

Naiyer Rizvi, MD
Columbia University Irving Medical Center
New York, NY, US

Mark A. Socinski, MD
AdventHealth Cancer Institute
Orlando, FL, US

David Spigel, MD
Sarah Cannon Research Institute
Nashville, TN, US

Sample Report

Start discovering the insights

View Report


The report that will be produced on the basis of the meeting will discuss the following topics

  • Immunotherapy in Stage IV NSCLC
  • Immunotherapy in Stage I–III Lung Cancer
  • EGFR Mutation-Positive NSCLC (Resectable and Metastatic)
  • Targeting Other Gene Mutations (KRAS, HER2, MET [BRAF])
  • Targeting Gene Fusions (ALK, ROS1, NTRK [RET])

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.